COMMUNIQUÉS West-GlobeNewswire

Glass House Brands Reports Record Setting Second Quarter 2024 Financial Results
13/08/2024
- Greenhouse 5 completed its first full quarter of production and sales in Q2, outperforming expectations - Record quarterly highs included consolidated revenue and gross profit, wholesale biomass revenue and gross [...]
ANI Pharmaceuticals, Inc. Closes $316.25 Million Convertible Senior Notes Offering Including Full Exercise of Initial Purchasers’ Option to Purchase Additional Notes
13/08/2024
PRINCETON, N.J., Aug. 13, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the closing of its offering of $316,250,000 aggregate principal amount of 2.25% [...]
Alumis Reports Second Quarter 2024 Financial Results and Highlights Recent Development and Corporate Achievements
13/08/2024
– Initiated patient dosing in ESK-001 Phase 3 ONWARD clinical program in moderate-to-severe plaque psoriasis – – Initiated Phase 1 clinical trial for A-005 in healthy participants – – Completed IPO and private placement [...]
Senti Bio Announces Second Quarter 2024 Results and Reviews Recent Corporate and Pipeline Highlights
13/08/2024
– Dose finding ongoing in Phase 1 clinical trial of SENTI-202 for the treatment of relapsed/refractory hematologic malignancies including AML – – Commencement of $8 million grant award from CIRM for the clinical [...]
Psychemedics Corporation Reports Second Quarter 2024 Financial Results
13/08/2024
DALLAS, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Psychemedics Corporation (NASDAQ: PMD), the world’s leading provider of hair testing for drugs of abuse, today announced financial results for the second quarter ending June 30 [...]
Trinity Biotech to Announce Q2 2024 Financial Results
13/08/2024
Conference Call Scheduled for Wednesday, August 14, 2024 at 8:30 AM ET DUBLIN, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) (the “Company”), a commercial stage biotechnology company focused on [...]
Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
13/08/2024
Advanced to Cohort 6 in the Phase 1 dose-escalation clinical study of BDC-3042 in patients with advanced cancers Abstract accepted for BDC-4182, a claudin 18.2-targeting Boltbody TM ISAC at the Society for Immunotherapy [...]
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2024
13/08/2024
PORTLAND, Maine, Aug. 13, 2024 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically proven and [...]
Fate Therapeutics Reports Second Quarter 2024 Financial Results and Business Updates
13/08/2024
Enrollment Ongoing with FT819 1XX CAR T-cell Product Candidate in Phase 1 Autoimmunity Study; Single-agent Cyclophosphamide Included as Alternative Conditioning Regimen First Patient Treated with FT522 CAR NK Cell [...]
Gritstone bio Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
13/08/2024
-- Preliminary randomized Phase 2 data suggest GRANITE (personalized neoantigen vaccine) could drive meaningful clinical benefit in front-line metastatic microsatellite-stable colorectal cancer (MSS-CRC); mature [...]
Dyadic Announces Second Quarter 2024 Financial Results and Highlights Recent Company Progress
13/08/2024
Alternative Proteins Entered into a development and commercialization partnership for the sale of animal-free recombinant albumin products with Proliant Health and Biologicals Entered into a joint development agreement [...]
Asensus Surgical, Inc. Reports Operating and Financial Results for the Second Quarter 2024
13/08/2024
RESEARCH TRIANGLE PARK, N.C., Aug. 13, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical , Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, announced its operating and [...]
NeuroPace Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
13/08/2024
-- Revenue grew to $19.3 million in Q2 2024, a 17% increase over Q2 2023 -- -- Increased full-year 2024 revenue guidance to $76 million to $78 million -- -- Demonstrated continued operating discipline as evidenced by [...]
Tenax Therapeutics Reports Second Quarter 2024 Financial Results and Provides a Corporate Update
13/08/2024
Raised Gross Proceeds of Approximately $100 Million in a Private Placement with Leading Institutional Healthcare Investors Continuing to Enroll Patients in Phase 3 LEVEL Study with 39 Investigative Sites Initiated In [...]
Mineralys Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
13/08/2024
– Advance-HTN trial is approximately 90% enrolled; trial is anticipated to deliver topline data in Q1 2025 – – Enrollment ahead of schedule in Phase 3 pivotal Launch-HTN trial and on track to deliver topline data as [...]
BioRestorative Therapies Reports Second Quarter 2024 Financial Results and Provides Business Update
13/08/2024
MELVILLE, N.Y., Aug. 13, 2024 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a regenerative medicine innovator focused on stem cell-based therapies and [...]
Better Choice Company Inc. Announces Second Quarter 2024 Results
13/08/2024
Net Income Increased 190% to $2.7 million Year-Over-Year E PS Growth of 170% to $2.98 Year-Over-Year Adjusted EBITDA Increased 98% to less than $(0.1) million 1 Year-Over-Year Recognized $3.6 million Gain on [...]
Zevra Therapeutics Reports Second Quarter 2024 Financial Results and Corporate Highlights
13/08/2024
FDA advisory committee voted favorably that the data support arimoclomol as effective treatment for patients with NPC; PDUFA date of September 21, 2024 Pro forma June 30, 2024, cash, cash equivalents, investments and [...]
Singular Genomics Reports Recent Highlights and Second Quarter 2024 Financial Results
13/08/2024
SAN DIEGO, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and [...]

Pages